Last updated: August 4, 2021
Sponsor: University of California, Davis
Overall Status: Completed
Phase
1
Condition
Scalp Disorders
Eczema (Atopic Dermatitis - Pediatric)
Allergy
Treatment
N/AClinical Study ID
NCT03114111
408732
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Healthy subjects 18 years or older with seborrheic dermatitis of the face will beincluded.
Exclusion
Exclusion Criteria:
- Subjects who are taking systemic corticosteroids (at doses of prednisone greater thanor equal to 5 mg daily), antibiotics (PO, IM or IV) or using topical anti- fungals,steroids, antibiotics, permethrin, or calcineurin inhibitors within 2 weeks prior tothe study will be excluded.
- The exclusion criteria will also include the presence of other untreated inflammatoryconditions (such as lupus, atopic dermatitis, or psoriasis) or untreated malignancieson the face (including skin cancers such as basal cell carcinoma, squamous cellcarcinoma and melanoma).
- Any subjects with known or suspected hypersensitivity to any constituent of the studymedication or a history of photosensitivity due to conditions such as lupuserythematosus and porphyria will be excluded.
- Subjects who have had photodynamic therapy (PDT) to the face for any reason within thepast year will be excluded as well.
- Adults unable to consent, individuals under the age of 18, pregnant or breastfeedingwomen and prisoners will be excluded from the study.
Study Design
Total Participants: 12
Study Start date:
January 01, 2017
Estimated Completion Date:
December 04, 2019
Study Description
Connect with a study center
University of California, Davis
Sacramento, California
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.